Exchange: NASDAQ·Updated 01:32 PM EDT
News
all
press releases
Athira Pharma (NASDAQ:LONA) Shares Down 6.5% - Should You Sell?
Athira Pharma (NASDAQ:LONA) Stock Price Down 6.5% - Here's What Happened...
MarketBeat
Athira Pharma (NASDAQ:LONA) CEO Sells 5,156 Shares
Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) CEO Mark James Litton sold 5,156 shares of the stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price...
MarketBeat

Advertisement|Remove ads.